Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Christopher Y Kim"'
Autor:
Tiffany A. Thomas, Annie Qiu, Christopher Y. Kim, Dominique E. Gordy, Anabel Miller, Maria Tredicine, Monika Dzieciatkowska, Flavia Dei Zotti, Eldad A. Hod, Angelo D’Alessandro, James C. Zimring, Steven L. Spitalnik, Krystalyn E. Hudson
Publikováno v:
Haematologica, Vol 108, Iss 10 (2023)
Although red blood cell (RBC) transfusions save lives, some patients develop clinically-significant alloantibodies against donor blood group antigens, which then have adverse effects in multiple clinical settings. Few effective measures exist to prev
Externí odkaz:
https://doaj.org/article/be762cf3fc3a4b8fac04d5d92fbd6d25
Autor:
Christopher Y. Kim, Hannah Johnson, Sandy Peltier, Steven L. Spitalnik, Eldad A. Hod, Richard O. Francis, Krystalyn E. Hudson, Elizabeth F. Stone, Dominique E. Gordy, Xiaoyun Fu, James C. Zimring, Pascal Amireault, Paul W. Buehler, Robert B. Wilson, Angelo D’Alessandro, Mikhail S. Shchepinov, Tiffany Thomas
Publikováno v:
Frontiers in Physiology, Vol 13 (2022)
Background: Long-chain polyunsaturated fatty acids (PUFAs) are important modulators of red blood cell (RBC) rheology. Dietary PUFAs are readily incorporated into the RBC membrane, improving RBC deformability, fluidity, and hydration. However, enrichi
Externí odkaz:
https://doaj.org/article/407397afc9144ac09431a2d172e70bba
Autor:
Tiffany A. Thomas, Annie Qiu, Christopher Y. Kim, Dominique E. Gordy, Anabel Miller, Maria Tredicine, Monika Dzieciatkowska, Flavia Dei Zotti, Eldad A. Hod, Angelo D’Alessandro, James C. Zimring, Steven L. Spitalnik, Krystalyn E. Hudson
Publikováno v:
bioRxiv
Although red blood cell (RBC) transfusions save lives, some patients develop clinically-significant alloantibodies against donor blood group antigens, which then have adverse effects in multiple clinical settings. Few effective measures exist to prev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b0fbbe003a0b4f938b524a8a8e2401d
https://europepmc.org/articles/PMC9900826/
https://europepmc.org/articles/PMC9900826/
Autor:
Tiffany Thomas, Annie Qiu, Christopher Y Kim, Dominique E Gordy, Anabel Miller, Maria Tredicine, Elizabeth Stone, Monika Dzieciatkowska, Eldad A. Hod, Angelo D'Alessandro, Steven L Spitalnik, James C Zimring, Imo J Akpan, Chance John Luckey, Krystalyn E Hudson
Publikováno v:
Blood. 140:75-76
Autor:
Dasan M. Thamattoor, Cassidy M. Madison, Christopher Y. Kim, William H. Miles, Daniel J. Sweitzer, Shelby D. Valent
Publikováno v:
Journal of Organometallic Chemistry. 851:218-224
The synthesis of stemofurans C, L and T was achieved using organomanganese arene complexes. The critical carbon-carbon bond between the C-2 position of benzofuran and the arene was established in a regioselective manner directed by the cationic manga
Autor:
Mi-Hyang Jung, Chang Seok Bang, Sang Min Park, Haemin Jeong, Christopher Y. Kim, Kyung Soon Hong, Myeong Ki Hong
Publikováno v:
Contemporary Clinical Trials. 60:51-55
Background Atrial fibrillation (AF) increases the risk of thromboembolic stroke. An oral anticoagulant should be administrated to prevent stroke in patients with moderate stroke risk (ie, CHA 2 DS 2 -VASc score > 2). If the stroke risk is low (i.e. t
Autor:
Christopher Y. Kim, Ann N. Behrens, Richard Shlofmitz, Brad J. Martinsen, Jeffrey W. Chambers, Arthur C. Lee, Michael S. Lee
Publikováno v:
Catheterization and Cardiovascular Interventions. 91:1018-1025
Objectives The goal of the study was to investigate the safety and efficacy of the coronary orbital atherectomy system to treat severe coronary artery calcification (CAC) prior to stent placement in diabetic and non-diabetic patients. Background The
Autor:
Jeffrey W. Moses, Richard Shlofmitz, Björn Redfors, Jeffrey W. Chambers, Christopher Y. Kim, Arthur C. Lee, Philippe Généreux, Michael S. Lee, Gregg W. Stone, Nicolas Bettinger
Publikováno v:
Catheterization and Cardiovascular Interventions. 88:369-377
Objectives We report 2-year outcomes of the Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions (ORBIT II) trial, with emphasis on the impact of stent type. Background The ORBIT II trial demonstrated the safety and
Publikováno v:
Catheterization and Cardiovascular Interventions. 87:671-677
Objectives The aim of this analysis is to evaluate potential differences according to gender in terms of acute and 30-day clinical outcomes in patients enrolled in the ORBIT II trial with de novo, severely calcified coronary lesions treated with orbi
Autor:
Georges Y. Nseir, Prakash Makam, Puneet K. Khanna, Zaheed Tai, Robert L. Feldman, Daniel Dulas, Thomas Davis, Christopher Y. Kim, Kirit Patel, Stevan I. Himmelstein, Arthur C. Lee, Neil E. Strickman, Richard Shlofmitz, Augusto E. Villa, Dinesh Arab, Joseph Puma, Rohit Bhatheja, Magdi G.H. Ghali, Barry D. Bertolet, Jeffrey W. Chambers, Rakesh R. Shah
Publikováno v:
JACC: Cardiovascular Interventions. 7:510-518
ObjectivesThe ORBIT II (Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions) trial evaluated the safety and efficacy of the coronary Orbital Atherectomy System (OAS) to prepare de novo, severely calcified coronary